Catalyst Biosciences CEO Nassim Usman's 2020 pay rises 18% to $1.4M

Catalyst Biosciences reports 2020 executive compensation

By ExecPay News

Published: April 27, 2021

Catalyst Biosciences reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, three executives at Catalyst Biosciences received on average a compensation package of $1.1M, a 33% increase compared to previous year.
Average pay of disclosed executives at Catalyst Biosciences
Nassim Usman, Chief Executive Officer, received $1.4M in total, which increased by 18% compared to 2019. 45% of Usman's compensation, or $640K, was in option awards. Usman also received $179K in non-equity incentive plan, $574K in salary, as well as $16K in other compensation.
Clinton Musil, Chief Financial Officer, received a compensation package of $967K. 72% of the compensation package, or $696K, was in option awards.
Howard Levy, Chief Medical Officer, earned $827K in 2020, a 13% increase compared to previous year.

Related executives

Nassim Usman

Catalyst Biosciences

Chief Executive Officer

Clinton Musil

Catalyst Biosciences

Chief Financial Officer

Howard Levy

Catalyst Biosciences

Chief Medical Officer

You may also like

Source: SEC filing on April 27, 2021.